Pelican-Cancer-Foundation-logos
Donate Now
Search
Pelican-Cancer-Foundation-logos

Dedicated to helping patients with bowel and liver cancer live well for longer

Donate Now
Search
  • Home
  • About us
    • About us
    • What we do
      • Our achievements
      • The Future
    • Who we are
      • Trustees
      • Our Team
      • Patrons
      • Annual Accounts
    • Partnerships
    • Vacancies
    • News
  • Education
    • Pelican OReCO
      • OReCO On-line Resources
      • OReCO Partners & Sponsors
      • Pelican OReCO Workshops
    • Pelican IMPACT
      • IMPACT – Completion & Evaluation
      • Workshops
      • IMPACT – Online resources
      • IMPACT – Partners and Sponsors
    • SPECC
      • SPECC – Completion & Evaluation
      • Workshops
      • SPECC – Online resources
      • SPECC – Partners and Sponsors
    • LOREC
    • TIPTOP
      • Workshops
      • TIPTOP – Online resources
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
    • LARS
    • Sponsors
      • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Films
  • Research
    • MERCURY 3
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Previous Research Areas
      • Prostate Cancer Research
        • Prostate cancer
        • Focal therapy and HIFU research
        • MRI research for prostate cancer
        • Prostate cancer colloquiums
        • FORECAST
        • Trachtomap
        • Papers of interest
      • Bladder cancer research
        • Bladder cancer
        • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for research applicants
      • Peer Review Panel Terms of Reference
      • Research Review Panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • April – Bowel Cancer Awareness Month
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Pseudomyxoma peritonei
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Shares
      • In memory
    • Fundraise for us
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
    • Leave a Gift in your Will
    • Become a Corporate Partner
    • Trusts, Foundations & Philanthropy
    • Tell us your story
  • Contact us

SPECCtacular launch of national programme to fight bowel cancer

July 19, 2017 by pelicanadmin

The SPECC | Significant Polyp & Early Colorectal Cancer programme launched with a first workshop in London, bringing together 80 cancer specialists from the London Cancer strategic clinical network to discuss ways of identifying bowel cancer earlier, improving precision treatment and helping patients live better for longer.

This national programme is expected to have a profound impact on the diagnosis and treatment of early colorectal cancer and to change clinical practice across England and Wales. Delegates from the London workshop confirmed that the SPECC programme helped them identify changes in clinical practice they would initiate at their hospitals as a result of the workshop. Changes to clinical practice include better assessment of size, position and appearance of polyps through improved methods of diagnosis and imaging such as higher resolution MRI, more standardised reporting of polyps, and drawing on expertise from different cancer specialists by discussing significant polyps as a team in MDTs. As well as local treatment strategies, teams were also encouraged to develop their regional partnerships to help provide consistent treatment options across England and Wales.

The next workshop will take place on 22nd January 2016, bringing together cancer specialists from the York and Humber strategic clinical network. The programme will tour the strategic clinical networks throughout 2015-2017, as Pelican Cancer Foundation invites six core members from all 164 Colorectal Cancer Multi-Disciplinary Teams (MDTs) in England and Wales.

Pelican Cancer Foundation is a charity with an exceptional reputation for developing high-impact national and international courses and meetings to improve patient care for cancer patients.

SPECC is endorsed by The Association of Coloproctology of Great Britain and Ireland, Beating Bowel Cancer, Bowel Cancer UK, Hampshire Hospitals NHS Foundation Trust, The Royal College of Pathologists and kindly supported by industry sponsors, including (from September 2015 to June 2016) Gold Sponsor Exact Sciences.

For further information on the SPECC programme, go to www.pelicancancer.org/specc
For further information about the Pelican Cancer Foundation, go to www.pelicancancer.org 
Twitter: @Pelican_Cancer #SPECCPOLYP 

Filed Under: Uncategorized

Stay in touch

Sign up to hear from us
Donate Now

© 2023 Pelican Cancer Foundation - all rights reserved

  Registered Charity Number: 1141911 -  Privacy Policy